Compare $VSBC vs $XBIO | Chartloom

Compare

$VSBC vs $XBIO

Vitaspring Biomedical Co. Ltd · Xenetic Biosciences Inc

VSBC

Vitaspring Biomedical Co. Ltd

XBIO

Xenetic Biosciences Inc

Compare $VSBC vs $XBIO

Comparing Vitaspring Biomedical Co. Ltd and Xenetic Biosciences Inc

VSBCVitaspring Biomedical Co. Ltd

XBIOXenetic Biosciences Inc

VSBCVitaspring Biomedical Co. Ltd

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-100.0%

52W performance

-100.0%

FCF yield

0.1%

XBIOXenetic Biosciences Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

33.3%

YTD performance

-0.9%

52W performance

-79.4%

FCF yield

-47.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

VSBC

XBIO

Detailed metrics comparison

VSBC

Vitaspring Biomedical Co. Ltd

XBIO

Xenetic Biosciences Inc

Market Cap

VSBC$7M

XBIO$5M

Enterprise Value

VSBC$9M

XBIO$-2M

Price

VSBC$0.00

XBIO$2.13

P/E Ratio

VSBCN/A

XBION/A

P/S Ratio

VSBC0.99x

XBIO1.50x

EV/Sales

VSBC0.99x

XBIO-0.49x

EV/EBITDA

VSBC4.29x

XBIO0.00x

P/B Ratio

VSBC3.92x

XBIO0.81x

P/FCF Ratio

VSBC765.53x

XBION/A

EV/FCF

VSBC1,044.32x

XBIO0.69x

PEG Ratio

VSBCN/A

XBION/A

Forward P/E (NTM)

VSBCN/A

XBION/A

Forward P/S (NTM)

VSBCN/A

XBION/A

Revenue (TTM)

VSBC$0

XBIO$3M

Revenue Growth (YoY)

VSBCN/A

XBIO33.3%

Forward Rev Growth

VSBC0.0%

XBIO-16.7%

Gross Margin (TTM)

VSBC39.3%

XBIO98.7%

Operating Margin (TTM)

VSBC23.4%

XBIO0.0%

EBITDA Margin (TTM)

VSBC0.0%

XBIO-81.0%

Net Margin (TTM)

VSBC18.2%

XBIO-75.9%

FCF Margin (TTM)

VSBCN/A

XBIO-70.9%

Net Income (TTM)

VSBC$-456K

XBIO$-2M

FCF (TTM)

VSBC$9K

XBIO$-2M

EPS (TTM)

VSBC-$0.00

XBIO-$1.08

ROE (TTM)

VSBC70.0%

XBIO-4062.0%

ROA (TTM)

VSBC-211240.0%

XBIO-3497.0%

ROIC (TTM)

VSBC70.0%

XBIO-4062.0%

Cash

VSBC$13K

XBIO$6M

Debt

VSBC$2M

XBIO$0

Net Cash/Debt

VSBC$-2M

XBIO$6M

Current Ratio (TTM)

VSBC0.00x

XBIO7.43x

Quick Ratio (TTM)

VSBC0.00x

XBIO7.23x

Debt/Equity (TTM)

VSBC0.00x

XBIO0.00x

Debt/Assets (TTM)

VSBC0.0%

XBIO0.0%

Interest Coverage (TTM)

VSBCN/A

XBION/A

Net Debt/EBITDA (TTM)

VSBC0.00x

XBIO0.00x

Beta

VSBC-1.47

XBIO2.36

52W Performance

VSBC-100.0%

XBIO-79.4%

YTD Performance

VSBC-100.0%

XBIO-0.9%

% from 52W High

VSBC-100.0%

XBIO-79.2%

% from 52W Low

VSBCN/A

XBIO13.9%

Asset Turnover (TTM)

VSBC2.66x

XBIO0.46x

FCF Yield (TTM)

VSBC0.1%

XBIO-47.4%

Earnings Yield (TTM)

VSBC-6.9%

XBIO-50.7%

Dividend Yield (TTM)

VSBCN/A

XBION/A

Rule of 40

VSBC0.0

XBIO-37.6

EV/GP/RG

VSBCN/A

XBION/A

Ticker research

View VSBC research View XBIO research

Metric	VSBC Vitaspring Biomedical Co. Ltd	XBIO Xenetic Biosciences Inc
Market & Valuation
Market Cap	$7M	$5M
Enterprise Value	$9M	$-2M
Price	$0.00	$2.13
P/E Ratio	N/A	N/A
P/S Ratio	0.99x	1.50x
EV/Sales	0.99x	-0.49x
EV/EBITDA	4.29x	0.00x
P/B Ratio	3.92x	0.81x
P/FCF Ratio	765.53x	N/A
EV/FCF	1,044.32x	0.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	33.3%
Forward Rev Growth	0.0%	-16.7%
Profitability
Gross Margin (TTM)	39.3%	98.7%
Operating Margin (TTM)	23.4%	0.0%
EBITDA Margin (TTM)	0.0%	-81.0%
Net Margin (TTM)	18.2%	-75.9%
FCF Margin (TTM)	N/A	-70.9%
Net Income (TTM)	$-456K	$-2M
FCF (TTM)	$9K	$-2M
EPS (TTM)	-$0.00	-$1.08
ROE (TTM)	70.0%	-4062.0%
ROA (TTM)	-211240.0%	-3497.0%
ROIC (TTM)	70.0%	-4062.0%
Financial Health
Cash	$13K	$6M
Debt	$2M	$0
Net Cash/Debt	$-2M	$6M
Current Ratio (TTM)	0.00x	7.43x
Quick Ratio (TTM)	0.00x	7.23x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.47	2.36
52W Performance	-100.0%	-79.4%
YTD Performance	-100.0%	-0.9%
% from 52W High	-100.0%	-79.2%
% from 52W Low	N/A	13.9%
Efficiency & Yields
Asset Turnover (TTM)	2.66x	0.46x
FCF Yield (TTM)	0.1%	-47.4%
Earnings Yield (TTM)	-6.9%	-50.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-37.6
EV/GP/RG	N/A	N/A
Ticker research	View VSBC research	View XBIO research

Valuation

P/S Ratio

VSBC

0.99x

XBIO

1.50x

EV/FCF

XBIO

0.69x

VSBC

1,044.32x

Growth & revenue

Revenue Growth TTM

XBIO

33.3%

Forward Revenue Growth

VSBC

0.0%

XBIO

-16.7%

Profitability & performance

Gross Margin

XBIO

98.7%

VSBC

39.3%

ROE

VSBC

70.0%

XBIO

-4062.0%

FCF Yield %

VSBC

0.1%

XBIO

-47.4%

52-Week Performance

XBIO

-79.4%

VSBC

-100.0%

Detailed metrics comparison

VSBC

Vitaspring Biomedical Co. Ltd

XBIO

Xenetic Biosciences Inc

Market Cap

VSBC$7M

XBIO$5M

Enterprise Value

VSBC$9M

XBIO$-2M

Price

VSBC$0.00

XBIO$2.13

P/E Ratio

VSBCN/A

XBION/A

P/S Ratio

VSBC0.99x

XBIO1.50x

EV/Sales

VSBC0.99x

XBIO-0.49x

EV/EBITDA

VSBC4.29x

XBIO0.00x

P/B Ratio

VSBC3.92x

XBIO0.81x

P/FCF Ratio

VSBC765.53x

XBION/A

EV/FCF

VSBC1,044.32x

XBIO0.69x

PEG Ratio

VSBCN/A

XBION/A

Forward P/E (NTM)

VSBCN/A

XBION/A

Forward P/S (NTM)

VSBCN/A

XBION/A

Revenue (TTM)

VSBC$0

XBIO$3M

Revenue Growth (YoY)

VSBCN/A

XBIO33.3%

Forward Rev Growth

VSBC0.0%

XBIO-16.7%

Gross Margin (TTM)

VSBC39.3%

XBIO98.7%

Operating Margin (TTM)

VSBC23.4%

XBIO0.0%

EBITDA Margin (TTM)

VSBC0.0%

XBIO-81.0%

Net Margin (TTM)

VSBC18.2%

XBIO-75.9%

FCF Margin (TTM)

VSBCN/A

XBIO-70.9%

Net Income (TTM)

VSBC$-456K

XBIO$-2M

FCF (TTM)

VSBC$9K

XBIO$-2M

EPS (TTM)

VSBC-$0.00

XBIO-$1.08

ROE (TTM)

VSBC70.0%

XBIO-4062.0%

ROA (TTM)

VSBC-211240.0%

XBIO-3497.0%

ROIC (TTM)

VSBC70.0%

XBIO-4062.0%

Cash

VSBC$13K

XBIO$6M

Debt

VSBC$2M

XBIO$0

Net Cash/Debt

VSBC$-2M

XBIO$6M

Current Ratio (TTM)

VSBC0.00x

XBIO7.43x

Quick Ratio (TTM)

VSBC0.00x

XBIO7.23x

Debt/Equity (TTM)

VSBC0.00x

XBIO0.00x

Debt/Assets (TTM)

VSBC0.0%

XBIO0.0%

Interest Coverage (TTM)

VSBCN/A

XBION/A

Net Debt/EBITDA (TTM)

VSBC0.00x

XBIO0.00x

Beta

VSBC-1.47

XBIO2.36

52W Performance

VSBC-100.0%

XBIO-79.4%

YTD Performance

VSBC-100.0%

XBIO-0.9%

% from 52W High

VSBC-100.0%

XBIO-79.2%

% from 52W Low

VSBCN/A

XBIO13.9%

Asset Turnover (TTM)

VSBC2.66x

XBIO0.46x

FCF Yield (TTM)

VSBC0.1%

XBIO-47.4%

Earnings Yield (TTM)

VSBC-6.9%

XBIO-50.7%

Dividend Yield (TTM)

VSBCN/A

XBION/A

Rule of 40

VSBC0.0

XBIO-37.6

EV/GP/RG

VSBCN/A

XBION/A

Ticker research

View VSBC research View XBIO research

Metric	VSBC Vitaspring Biomedical Co. Ltd	XBIO Xenetic Biosciences Inc
Market & Valuation
Market Cap	$7M	$5M
Enterprise Value	$9M	$-2M
Price	$0.00	$2.13
P/E Ratio	N/A	N/A
P/S Ratio	0.99x	1.50x
EV/Sales	0.99x	-0.49x
EV/EBITDA	4.29x	0.00x
P/B Ratio	3.92x	0.81x
P/FCF Ratio	765.53x	N/A
EV/FCF	1,044.32x	0.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	33.3%
Forward Rev Growth	0.0%	-16.7%
Profitability
Gross Margin (TTM)	39.3%	98.7%
Operating Margin (TTM)	23.4%	0.0%
EBITDA Margin (TTM)	0.0%	-81.0%
Net Margin (TTM)	18.2%	-75.9%
FCF Margin (TTM)	N/A	-70.9%
Net Income (TTM)	$-456K	$-2M
FCF (TTM)	$9K	$-2M
EPS (TTM)	-$0.00	-$1.08
ROE (TTM)	70.0%	-4062.0%
ROA (TTM)	-211240.0%	-3497.0%
ROIC (TTM)	70.0%	-4062.0%
Financial Health
Cash	$13K	$6M
Debt	$2M	$0
Net Cash/Debt	$-2M	$6M
Current Ratio (TTM)	0.00x	7.43x
Quick Ratio (TTM)	0.00x	7.23x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.47	2.36
52W Performance	-100.0%	-79.4%
YTD Performance	-100.0%	-0.9%
% from 52W High	-100.0%	-79.2%
% from 52W Low	N/A	13.9%
Efficiency & Yields
Asset Turnover (TTM)	2.66x	0.46x
FCF Yield (TTM)	0.1%	-47.4%
Earnings Yield (TTM)	-6.9%	-50.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-37.6
EV/GP/RG	N/A	N/A
Ticker research	View VSBC research	View XBIO research